NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of DexCom, Inc. (NASDAQ: DXCM). Shareholders who purchased shares of DXCM during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/dexcom-inc-loss-submission-form-2/?id=178599&from=3 CLASS PERIOD: January 8, 2024 to ...

SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements concerning Perrigo business and prospects, resulting in its stock trading at inflated prices. ...

LOS ANGELES, Nov. 20, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Perrigo Company plc, (“Perrigo” or the "Company") (NYSE: PRGO) investors off a class action on behalf of investors that bought securities between February 27, 2023 and November 4, 2025, inclusive (the “Class Period”). Perrigo investors have until January 16, 2026 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: lesley@portnoylaw.com, to discuss their leg ...

Core Points - The Gross Law Firm has issued a notice to shareholders of CarMax, Inc. regarding a class action lawsuit for alleged misleading statements made by the company during the class period from June 20, 2025, to September 24, 2025 [1] - The allegations include that CarMax's growth prospects were overstated and that earlier growth was a temporary effect due to customer speculation about tariffs, leading to materially false and misleading statements about the company's business and operations [1] Summary by Sections Class Action Details - Shareholders who purchased shares of CarMax during the specified class period are encouraged to contact the Gross Law Firm for potential lead plaintiff appointment [1] - The deadline for shareholders to register for the class action is January 2, 2026, and there is no cost or obligation to participate [2] Law Firm's Mission - The Gross Law Firm aims to protect the rights of investors who have suffered due to deceit, fraud, and illegal business practices, ensuring companies adhere to responsible business practices [3]

ALLEGATIONS: According to the filed complaint, defendants made false statements and/or concealed that the merger integration between Primo Water and BlueTriton Brands was tracking poorly due to, among other things, technology and service issues. Moreover—and contrary to defendants' statements assuring investors that the execution was "flawless"—Primo Brands was having major supply disruptions which would negatively impact customers and thus Primo Brands' financial results. Accessibility StatementSkip Naviga ...

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of DexCom, Inc. regarding a class action lawsuit alleging that the company made misleading statements about its glucose monitoring products, the G6 and G7, which were not authorized by the FDA and posed health risks to users [1]. Group 1: Allegations Against DexCom - The lawsuit claims that DexCom made unauthorized design changes to the G6 and G7 glucose monitoring devices, which rendered them less reliable than previous versions [1]. - It is alleged that the enhancements to the G7's reliability, accuracy, and functionality were overstated, and the company downplayed the severity of the issues related to the devices [1]. - The complaint suggests that these actions increased the risk of regulatory scrutiny and potential legal, reputational, and financial harm to DexCom [1]. Group 2: Class Action Details - The class period for the lawsuit is defined as January 8, 2024, to September 17, 2025, and shareholders are encouraged to register for participation [2]. - The deadline for shareholders to seek lead plaintiff status is December 26, 2025, and there is no cost to participate in the case [2]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the lifecycle of the case [2].

Core Viewpoint - RCI Hospitality Holdings, Inc. is facing a class action lawsuit due to allegations of bribery and tax fraud, which has significantly impacted its stock price [1][3]. Allegations - The lawsuit claims that RCI executives engaged in tax fraud and bribery to conceal this fraud, leading to an understatement of the legal risks associated with the company [3]. - Following the announcement of the indictment by New York State Attorney General Letitia James, RCI's stock price dropped by $5.53 (16%) to close at $28.79 on September 16, 2025, and further fell by $2.99 (10.38%) to close at $25.80 on September 17, 2025 [3]. Class Action Participation - Shareholders interested in participating as lead plaintiffs in the class action must submit their papers by November 20, 2025, but they can also remain absent class members without taking action [4]. - The representation in the class action is on a contingency fee basis, meaning shareholders will not incur any fees or expenses [5].

Core Viewpoint - Class actions have been initiated on behalf of stockholders of Baxter International, Spirit Aviation Holdings, and Molina Healthcare, with specific allegations of misleading statements and undisclosed risks during designated class periods [1]. Baxter International, Inc. (NYSE:BAX) - Class Period: February 23, 2022 to July 30, 2025 - Lead Plaintiff Deadline: December 15, 2025 - Allegations include systemic defects in the Novum LVP leading to malfunctions that posed serious risks to patients, inadequate remedial measures by Baxter, and misleading statements regarding the safety and efficacy of the product [5]. Spirit Aviation Holdings, Inc. (OTCMKTS:FLYYQ) - Class Period: May 28, 2025 to August 29, 2025 - Lead Plaintiff Deadline: December 1, 2025 - Allegations state that Spirit failed to disclose substantial risks of financial instability and potential bankruptcy, leading to a significant drop in stock price after the announcement of Chapter 11 filing [5]. Molina Healthcare, Inc. (NYSE:MOH) - Class Period: February 5, 2025 to July 23, 2025 - Lead Plaintiff Deadline: December 2, 2025 - Allegations include failure to disclose adverse facts regarding medical cost trends and misleading statements about the company's growth prospects, which could lead to a reduction in financial guidance for fiscal year 2025 [6].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of LifeMD, Inc. regarding a class action lawsuit due to alleged misleading statements and failure to disclose critical information during a specified class period [1][3]. Summary by Sections Class Period and Allegations - The class period for the lawsuit is from May 7, 2025, to August 5, 2025 [3]. - Allegations include that LifeMD's management overstated the company's competitive position and raised 2025 guidance without properly accounting for rising customer acquisition costs, particularly in the RexMD segment and for obesity treatment drugs like Wegovy and Zepbound [3]. Next Steps for Shareholders - Shareholders are encouraged to register for the class action by October 25, 2025, to potentially become lead plaintiffs [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's progress [4]. Law Firm's Mission - The Gross Law Firm aims to protect investors' rights against deceit and fraud, ensuring companies adhere to responsible business practices [5].

Core Viewpoint - Tronox Holdings plc is facing a class action lawsuit due to allegations of providing misleading statements about its financial health and sales forecasts, leading to a significant drop in stock price [3][4]. Summary by Sections Allegations - The complaint alleges that Tronox made overly positive statements while concealing material adverse facts about its commercial division and sales forecasts for its pigment and zircon products [3]. - Despite optimistic long-term projections, Tronox's forecasting processes failed, resulting in declining sales and increased costs, which derailed revenue projections [3]. Financial Impact - On July 30, 2025, Tronox reported a significant reduction in TiO2 sales, attributing the decline to a softer coatings season and heightened competition [3]. - Following the announcement, Tronox revised its 2025 financial outlook, lowering full-year revenue guidance and cutting its dividend by 60% [3]. - The stock price plummeted from $5.14 per share on July 30, 2025, to $3.19 per share on July 31, 2025, marking a decline of approximately 38% in one day [3]. Class Action Details - Shareholders who purchased shares during the class period from February 12, 2025, to July 30, 2025, are encouraged to register for the class action [4]. - The deadline for seeking lead plaintiff status is November 3, 2025, and there is no cost to participate in the case [4].